MYC expression	Triple Negative Breast Cancer	MYC expression	Triple Negative Breast Cancer	pembrolizumab + MK-7965 Sensitive: C3 – Early Trials pembrolizumab + MK-7965 Sensitive : C3	pembrolizumab + MK-7965 Sensitive: C3 – Early Trials pembrolizumab + MK-7965 Sensitive : C3
CDK9 overexpression	Uveal Melanoma	CDK9 overexpression	Uveal Melanoma	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D
CDK7 overexpression	Uveal Melanoma	CDK7 overexpression	Uveal Melanoma	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D
CCNE1 overexpression	Ovarian Cancer	CCNE1 overexpression	Ovarian Cancer	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D
CCNE1 amplification	Ovarian Cancer	CCNE1 amplification	Ovarian Cancer	MK-7965 Sensitive: D – Preclinical MK-7965 Sensitive : D	MK-7965 Sensitive: D – Preclinical MK-7965 Sensitive : D
CCNE1 amplification	Ovarian Cancer	CCNE1 amplification	Ovarian Cancer	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D	SNS-032 Sensitive: D – Preclinical SNS-032 Sensitive : D
CDKN2A deletion	Pancreatic Ductal Adenocarcinoma	CDKN2A deletion	Pancreatic Ductal Adenocarcinoma	BET inhibitor + CDK inhibitor Sensitive: D – Preclinical BET inhibitor + CDK inhibitor Sensitive : D	BET inhibitor + CDK inhibitor Sensitive: D – Preclinical BET inhibitor + CDK inhibitor Sensitive : D
FLT3-ITD expression	Acute Myelogenous Leukemia	FLT3-ITD expression	Acute Myelogenous Leukemia	gilteritinib + MK-7965 Sensitive: D – Preclinical gilteritinib + MK-7965 Sensitive : D	gilteritinib + MK-7965 Sensitive: D – Preclinical gilteritinib + MK-7965 Sensitive : D
ZNF765 overexpression	Hepatocellular Cancer	ZNF765 overexpression	Hepatocellular Cancer	PHA 793887 Sensitive: D – Preclinical PHA 793887 Sensitive : D	PHA 793887 Sensitive: D – Preclinical PHA 793887 Sensitive : D
RAC1 P29S	Melanoma	RAC1 P29S	Melanoma	MK-7965 Sensitive: D – Preclinical MK-7965 Sensitive : D	MK-7965 Sensitive: D – Preclinical MK-7965 Sensitive : D

CDK inhibitor

CDK inhibitor

Associations(10)

Associations
(10)